【宜明昂科-B(01541.HK):IMC-003/IMM72获国家药监局批准进行临床试验】智通财经APP讯,宜明昂科-

智通财经
Jun 23, 2025
【宜明昂科-B(01541.HK):IMC-003/IMM72获国家药监局批准进行临床试验】智通财经APP讯,宜明昂科-B(01541.HK)发布公告,该集团获得中国国家药品监督管理局(“国家药监局”)有关启动IMC-003/IMM72治疗肺动脉高压(PAH) 的临床试验的新药临床试验(IND)批准。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10